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Abstract 
Introduction: Meningioma is slow growing neoplasm cells that comes from arachnoid cap most common 
benign intracranial tumours. Olfactory groove meningiomas (OGM) account for 8–13% of all intracranial 
meningiomas. Intracranial tumors on pregnancy is a rare event, with few reports. 
Case Presentation: A 36-year-old- female (G11P9A1) 34 gestational week presented to the Adam Malik 
General Hospital with smelling disturbances for 6 months and lossing smelling sense in the past 1 month. 
Slowly progression of vision disturbances for 3 months without improvement in using glasses, progressive loss 
of vision in both eyes for the past 1 month. CT scan and MRI revealead a solid mass lesion, with 6.3 x 4.2 x 3.1 
cm. It was a supratentorial in frontal region, olfactory groove mass. The Craniotomy tumor removal was 
performed in this patient. 
Discussion: Meningiomas are mostly silent brain tumors with slow growth, however may get detected and 
mostly become symptomatic during pregnancy and luteal phase of menstrual cycle due to increase in size 
secondary to either water retention, enhanced vascularity or progesterones are possible etiologies. The majority 
of meningiomas express progesterone reseptor, which can be detected also by immunohistochemistry. In fact, 
tumour growth when progesterone concentrations are higher, shows the role of sex hormones in the mechanism. 
Regardless of the status of pregnancy, symptomatic and large meningiomas require surgical resection. 
Conclusion: Changes of plasma concentration hormones during pregnancy and their effect on meningioma 
growth in the second and third trimester are crucial and critical. The management of brain lesions during 
pregnancy required professional collaboration between neurosurgeons, obstetricians and anesthesiologists. 
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Introduction 
Meningioma is slow growing neoplasm cells that comes from arachnoid cap cells or 
meningothelial cells that cover the central nervous system, and most common benign 
intracranial tumours.[1][2][3] It gives neurological symptoms by compression of adjacent 
structures.[2] Incidence rate of 10%–20% of all intracranial neoplasms.[4] The highest 
incidence occurs in decades 5 to 6.[5] Female patient more likely to suffer from meningioma 
two or three times than males. During pregnancy and luteal phase in menstruation made 
meningioma become develop and grew faster, which a hypothesis phenomenon associated 
with a hormonal (endogenous and exogenous) pathway. The influence of female sex 
hormones are the growth and development of meningioma.[6] 
Intracranial tumors on pregnancy is a rare event, with few reports of brain tumour 
associated with pregnancy. Only seven pregnant women with primary brain tumors were 
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found among 126.413 pregnancies over 13 years, and two of them had meningiomas.[7] The 
underlying mechanism for this growth may consist of elevated serum estrogen and 
progesterone levels in pregnant patients.[4] Dramatic growth of meningiomas is occasionally 
encountered during pregnancy, and may exhibit accelerated growth during the second half of 
pregnancy.[8] As a result, rapid changes in meningioma size occur during pregnancy, putting 
both the mother and fetus at risk. Regardless of the status of pregnancy, symptomatic and 
large meningiomas require surgical resection. The management of brain lesions diagnosed 
during pregnancy is challenging to both neurosurgeons and obstetricians. 
 
Case Report 
A 36-year-old female grande-multigravida pregnancy (G11P9A1) 34 gestational week 
come to Haji Adam Malik General Hospital, with chief complain of smelling disturbances for 
6 months and lossing smelling sense in the past 1 month. Slowly progression of vision 
disturbances for 3 months without improvement in using glasses, progressive loss of vision in 
both eyes for the past 1 month. History of headache since 1 year ago. Without history of 
hormonal contraception. On physical examination patient was alert with neurological deficit 
bilateral anosmia and blindness in both eyes (Visus ODS : No light perception) . Billateral 
papil atrophy was found in funduscopy examination. Brain computed tomography (CT) scan 
and magnetic resonance imaging (MRI) revealead a solid extra-axial mass lesion with 
contrast enhancement, with size 6.3 x 4.2 x 3.1 cm (figure 1 and figure 2). The mass origin 




Figure 1. (A) MRI Brain Contrast Axial T1 (B) Axial T1 + contrast (C) 
MRI Brain Contrast Sagital T1 (D) Sagital T1 + contrast (E) Sagital T2 
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Figure 2. MRI Brain Contrast (A) Coronal T1 (B) Coronal T1 + 
contrast 
 
Based on ultrasound examination of pregnancy, fetus was in good condition, with a 
gestational age of 34-35 weeks (figure 3). Considerations from Obgyn department, if tumor 
removal surgery is to be performed, consider it to be done when the fetus is viable, joint 
operation with section caesaria procedure. As the condition of both patient and fetus, it was 
decided after consultation along with obgyn department to underwent tumour removal under 
general anasthesia with rapid sequence intubation. 
 
Figure 3. Pregnancy Ultrasound  
 
The patient underwent surgical intervention and perfomed in the supine position. The 
lesion was approach by a frontal craniotomy. A complete resection could be achieved by 8 
burr hole, and free bone flap 15 x 8 cm, the dura was opened, sinus sagitalis inferior ligasion 
and durotomy. Subarachnoid disection, devascularization and tumor debulking internally. 
The tumor was found to be firm, grey, tender, suctionable without spontaneus bleeding. No 
intraoperative complications occured, and the tumor was totally resected, with bleeding 
control before closure (figure 4). 
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Figure 4. Intraoperative (A) Marking incision (B) 
Frontal bone  (C) Duramater exposure  (D) Sinus 




Meningiomas account for approximately 15% of all intracranial neoplasms. 
Meningiomas are mostly silent brain tumors with slow growth, however may get detected and 
mostly become symptomatic during pregnancy and luteal phase of menstrual cycle due to 
increase in size secondary to either water retention, enhanced vascularity or progesterones are 
possible etiologies. [9][10] A cohort study, showed relationship between progesterone 
receptor status and the biological behavior of tumors. Patients with progesterone-positive 
tumors revealed decreased recurrence rates after tumor resection. [10] [11]  
Meningiomas rarely occur during pregnancy, estimated 5.6 cases out of 100,000 
pregnancies. Low incidence of meningioma because of fertility range is around 15-45 years 
and meningioma which have the highest incidence between the ages of 60 and 70 years. One 
important aspect of meningioma in pregnancy is the rapid growth with life-threatening 
complications. [12] [13]  
During pregnancy, FSH and LH and prolactin are low due to negative feedback 
mechanisms that affect the anterior hypophysis. FSH, LH and hCG glycoprotein in vitro 
study can inhibit tumor cell proliferation; in contrast, human placental lactogen (hPL) and 
prolactin (PRL) can stimulate tumor growth. The second and third trimester of pregnancy is 
very important and critical. [14][15] Estrogen receptors (ER) are not expressed in most 
meningiomas. The role of progesterone receptors (PR) where an inverse relationship between 
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protein expression and tumor.[15] While the rate of mitosis increases with a higher grade, 
meningiomas in pregnancy are mainly low grade. Therefore, it is questionable whether rapid 
tumor growth is related to cell proliferation induced by progesterone or not.[16] The majority 
of meningiomas express PR, which can be detected also by immunohistochemistry. In fact, 
tumour growth when progesterone concentrations are higher, shows the role of sex hormones 
in the mechanism. [16] [17] 
Tumors compress the surrounding structures can lead to most frequent symptoms 
such as headache, dizziness, focal lesions and epilepsy. The skull base is a common 
localization of meningiomas, progressive growth during pregnancy often results in visual 
impairment. [17] [18]  Optic nerve compression causes reduced venous return, resulting 
blurry and papillary oedem on funduscopy. Oculomotor nerve compression lead to functional 
deficits of intraocular muscles, anisocoria, pupillary dilatation and absence of light reactions. 
Surgical resection is still the main curative treatment of meningioma, and the rate of 
peritumoral brain edema is also decreases after successful neurosurgical intervention. Brain 
surgery during pregnancy is very risky for mother and child, so continuous intraoperative 
monitoring as well as professional collaboration between brain surgeons, obstetricians and 
anesthesiologists can not be avoided.[19] In this case, general anaesthesia can be safe in 
pregnant patients with intracranial tumours. Tracheal intubation is very important as it allows 
maternal hyperventilation thereby controlling raised intracranial pressure. [19] [20] 
 
Conclusion 
Giant gestational meningioma or meningioma in pregnancy are rarely occur, the 
underlying mechanism for this growth may consist of elevated serum estrogen and 
progesterone levels. As a result, rapid changes in meningioma size occur during pregnancy, 
putting both the mother and fetus at risk. Regardless of the status of pregnancy, symptomatic 
and large meningiomas require surgical resection. The management of brain lesions during 
pregnancy required professional collaboration between neurosurgeons, obstetricians and 
anesthesiologists. 
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